A new market analysis projects continued expansion in the global cell culture market through 2031, with demand supported by biopharmaceutical production and ongoing investment across research and manufacturing workflows. The report examines the industry by consumables, vessels, equipment, application, and competition, pointing to sustained interest in technologies used to grow and maintain cells in controlled lab settings.
Among applications, biopharmaceutical production was identified as the leading segment in 2025, underlining the central role of cell culture in drug development and biologics manufacturing. On the product side, sera, media, and reagents accounted for the largest share within consumables, reflecting their routine use across cell-based processes.
The outlook also highlights regional momentum, with Asia-Pacific expected to post the fastest growth through 2031. That trend suggests expanding life sciences capacity, broader manufacturing activity, and rising demand for modern laboratory infrastructure across key markets in the region.
Competition in the sector includes major life sciences and laboratory suppliers such as Thermo Fisher Scientific, Danaher, Sartorius, and Merck. Overall, the forecast points to a market shaped by recurring consumables demand, biopharma-led applications, and regional growth opportunities tied to expanding research and production capabilities.
